New Cancer Research Breakthrough: Biomarkers Help Predict Treatment Success
癌症研究新突破：生物標記助預測治療成效
Cancer treatment is undergoing a revolutionary shift toward precision oncology.
癌症治療正歷經一場趨向精準腫瘤學的革命性轉變。
Instead of a one-size-fits-all approach, doctors now use biomarkers—quantifiable biological indicators like proteins or DNA—to identify the unique molecular signature of a tumor.
醫師現在不再採用「一體適用」的方法，而是利用生物標記（亦稱生物指標）——即如蛋白質或DNA等可量化的生物指示劑——來辨識腫瘤獨特的分子特徵。
These tools allow clinicians to match patients with therapies specifically designed to target their cancer's drivers, significantly increasing success rates while minimizing side effects.
這些工具使臨床醫師能為病患配對專門針對其癌症致病因子的療法，在將副作用減至最低的同時，顯著提升治療成功率。
Predictive biomarkers act as guides for selecting targeted therapies or immunotherapy, while liquid biopsies offer a way to monitor treatment efficacy in real-time.
預測性生物標記可作為篩選標靶治療或免疫治療的指南，而液態切片則提供了即時監測療效的方式。
Furthermore, integrating genomics with proteomics and metabolomics provides a more holistic view of tumor biology.
此外，將基因體學與蛋白體學及代謝體學整合，能提供更全面的腫瘤生物學視角。
Despite challenges such as tumor heterogeneity and the difficulty of standardizing diagnostic tests, the field is moving toward ultrapersonalized medicine.
儘管面臨如腫瘤異質性（ㄧˋㄓˊㄒㄧㄥˋ）及診斷測試標準化困難等挑戰，但此領域正朝向超個人化醫療發展。
By focusing on the specific molecular makeup of a tumor rather than just its location, medical researchers are transforming cancer from an unpredictable enemy into a manageable condition, ultimately leading to more accurate, effective, and patient-centered outcomes.
透過專注於腫瘤的具體分子構成而非僅是其位置，醫學研究人員正在將癌症從一種無法預測的敵人轉變為可控制的疾病，最終帶來更準確、更有效且以病患為中心的成果。
